INVIBIO DEVICE COMPONENT MANUFACTURING LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -71.7%

  £708,735 → £200,401

• Cash

  +131.8%

  £13,720 → £31,803

• Net assets

  +195.1%

  £50,190 → £148,102

• Employees

  —

  Not reported

• Operating profit

  -81.2%

  £456,943 → £85,881

• Profit before tax

  -79.6%

  £462,431 → £94,517

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Abridged

Yes — abridged accounts (limited disclosure)

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Victrex plc will provide financial support to the Company such that the Company is able to operate as a going concern and to settle its liabilities as they fall due. In addition, the Company has received a pledge from its immediate parent, Invibio Limited, that it will not seek repayment of its receivable for a minimum of 15 months from the date of signing this Company's financial statements for the financial year ended 30 September 2025. For this reason, they continue to adopt the going concern basis for preparing the financial statements.”

Group structure

1. INVIBIO DEVICE COMPONENT MANUFACTURING LIMITED · parent
   1. Juvora Limited 100% · England · Active, non trading entity
   2. Invibio Knees Limited 100% · England · Producer of medical knee devices and components

Significant events

• “The Company has issued a financial guarantee contract in favour of Barclays Bank Plc ('Barclays') to cover any liabilities due to Barclays by the Company and its fellow UK subsidiaries up to a maximum value of £12m.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.